1. 733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy. (10th December 2020) Authors: Gjini, Evisa; Trillo-Tinoco, Jimena; Browne, Andrew; Powles, Ryan; Wang, Tai; Tauras, Christine; Lako, Ana; Ferrer-Luna, Ruben; Bleicher, Zoe; Consedine, Timothy; Zhou, Chensheng; Kelemen, Evan; Lewin, Anne; King, Catherine; Bhattacharya, Sumit; Bell-Temin, Harris; Dongre, Ashok; Nelson, David; H... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy. (9th November 2020) Authors: Gjini, Evisa; Trillo-Tinoco, Jimena; Browne, Andrew; Powles, Ryan; Wang, Tai; Tauras, Christine; Lako, Ana; Ferrer-Luna, Ruben; Bleicher, Zoe; Consedine, Timothy; Zhou, Chensheng; Kelemen, Evan; Lewin, Anne; King, Catherine; Bhattacharya, Sumit; Bell-Temin, Harris; Dongre, Ashok; Nelson, David; H... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma. (17th October 2016) Authors: Ibrahim, Nageatte; Buchbinder, Elizabeth I.; Granter, Scott R.; Rodig, Scott J.; Giobbie‐Hurder, Anita; Becerra, Carla; Tsiaras, Argyro; Gjini, Evisa; Fisher, David E.; Hodi, F. Stephen Journal: Cancer medicine Issue: Volume 5:Number 11(2016:Nov.) Page Start: 3041 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti‐leukaemic activity of the TYK2 selective inhibitor NDI‐031301 in T‐cell acute lymphoblastic leukaemia. (14th March 2017) Authors: Akahane, Koshi; Li, Zhaodong; Etchin, Julia; Berezovskaya, Alla; Gjini, Evisa; Masse, Craig E.; Miao, Wenyan; Rocnik, Jennifer; Kapeller, Rosana; Greenwood, Jeremy R.; Tiv, Hong; Sanda, Takaomi; Weinstock, David M.; Look, A. Thomas Journal: British journal of haematology Issue: Volume 177:Number 2(2017) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti‐PD‐1 Immunotherapy‐Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer. (14th May 2019) Authors: Nabel, Christopher S.; Severgnini, Mariano; Hung, Yin P.; Cunningham‐Bussel, Amy; Gjini, Evisa; Kleinsteuber, Katja; Seymour, Lake J.; Holland, Martha K.; Cunningham, Rachel; Felt, Kristin D.; Vivero, Marina; Rodig, Scott J.; Massarotti, Elena M.; Rahma, Osama E.; Harshman, Lauren C. Journal: Oncologist Issue: Volume 24:Number 8(2019) Page Start: 1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab. Issue 1 (18th July 2017) Authors: Moreira, Raphael B.; Hamieh, Lana; Gjini, Evisa; Lako, Ana; Krajewski, Katherine M.; Yoon, Charles H.; Ott, Patrick A. Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗